Jerzy Gruhn
Corporate Officer/Principal bij European Association For The Study of Diabetes
Profiel
Jerzy Gruhn is a member of the European Association For The Study of Diabetes.
He previously worked as a Director at Pharmaceutical Research & Manufacturers of America, Senior Vice President & Head-Europe Region at Novo Nordisk A, and President at Novo Nordisk, Inc. He graduated from the University of Warsaw in 1990.
Actieve functies van Jerzy Gruhn
| Bedrijven | Functie | Begin |
|---|---|---|
| European Association For The Study of Diabetes | Corporate Officer/Principal | - |
Eerdere bekende functies van Jerzy Gruhn
| Bedrijven | Functie | Einde |
|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | President | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Directeur/Bestuurslid | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Opleiding van Jerzy Gruhn
| University of Warsaw | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| European Association For The Study of Diabetes | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |